Journal of Clinical Endocrinology & Metabolism, Vol 81, 3379-3384, Copyright © 1996 by Endocrine Society

ARTICLES

Relaxin modulates human cervical stromal cell activity

JJ Hwang, D Macinga and EA Rorke
Department of Environmental Health Science and Reproductive Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.

The cervix undergoes profound changes in size and consistency during pregnancy which are designed to facilitate a normal delivery. These changes are under the control of a number of hormonal factors. Experimental and clinical studies suggest that relaxin, a protein hormone, plays a role in promoting cervical softening. One possible target site for the effects of relaxin on the cervix is the stroma. In the studies reported here, cultures of normal human cervical stromal cells were used to determine what direct relaxin has on cervical cells. Relaxin at concentrations ranging from 0.10-100 ng/mL had no effect on human cervical stromal cell proliferation, but was found to modulate stromal cell activity related to the remodeling of extracellular matrix. When gelatin substrate gels were used, relaxin stimulated the secretion of several cervical stromal proteinase activities, including 36,52, and 116 kDa. Inhibitor studies using ethylenediamine tetraacetate, 1,10-phenanthroline, and L-cysteine identify these gelatinases as metalloproteinases. Neither estradiol nor progesterone augmented the effects of relaxin. A relaxin-induced concentration- dependent increase in collagenase activity was observed when measured with a conventional collagen fibril assay. Finally, relaxin was found to increase glycosaminoglycan synthesis, as indicated by [3H]g- lycocyamine incorporation in human cervical stromal cell cultures. These results indicate the relaxin may regulate cervical ripening in humans, as it does in other species, by direct effects on cervical cells.

This article has been cited by other articles:

				D. J. Scott, S. Layfield, Y. Yan, S. Sudo, A. J. W. Hsueh, G. W. Tregear, and R. A. D. Bathgate Characterization of Novel Splice Variants of LGR7 and LGR8 Reveals That Receptor Signaling Is Mediated by Their Unique Low Density Lipoprotein Class A Modules J. Biol. Chem., November 17, 2006; 281(46): 34942 - 34954. [Abstract] [Full Text] [PDF]

				O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF]

				J. J. Luna, A. Riesewijk, J. A. Horcajadas, R. d. van Os, F. Dominguez, S. Mosselman, A. Pellicer, and C. Simon Gene expression pattern and immunoreactive protein localization of LGR7 receptor in human endometrium throughout the menstrual cycle Mol. Hum. Reprod., February 1, 2004; 10(2): 85 - 90. [Abstract] [Full Text] [PDF]

				J. L. Dragoo, R. S. Lee, P. Benhaim, G. A. M. Finerman, and S. L. Hame Relaxin Receptors in the Human Female Anterior Cruciate Ligament Am. J. Sports Med., July 1, 2003; 31(4): 577 - 584. [Abstract] [Full Text] [PDF]

				J. A. Lenhart, P. L. Ryan, K. M. Ohleth, and C. A. Bagnell Expression of Connexin-26, -32, and -43 Gap Junction Proteins in the Porcine Cervix and Uterus During Pregnancy and Relaxin-Induced Growth Biol Reprod, December 1, 1999; 61(6): 1452 - 1459. [Abstract] [Full Text]

				S. Zhao and O. D. Sherwood Monoclonal Antibodies Specific for Rat Relaxin. X. Endogenous Relaxin Induces Changes in the Histological Characteristics of the Rat Vagina During the Second Half of Pregnancy Endocrinology, November 1, 1998; 139(11): 4726 - 4734. [Abstract] [Full Text] [PDF]

				T. Kohsaka,, G. Min,, G. Lukas,, S. Trupin,, E. T. Campbell,, and O. D. Sherwood Identification of Specific Relaxin-Binding Cells in the Human Female Biol Reprod, October 1, 1998; 59(4): 991 - 999. [Abstract] [Full Text]